During the study, participating clinics will collaborate and share de-identified patient information in a protected data collection tool where the data will be tracked and analyzed.
To assist with treatment and data collection, FLCCC has partnered with five clinics operating across the United States. Each clinic participating in the study will work to collaborate with their patients’ respective cancer treatment teams to ensure treatment conforms to patients’ wishes and does not conflict with other treatments. Each patient is responsible for the cost of their participation in the study.
“We hope that our research will bring attention to often overlooked methods for treating cancer as well as managing the symptoms from conventional treatment,” said Paul E. Marik, MD, FCCM, FCCP, lead author of the study, chief scientific officer of the FLCCC and former Chief of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School.
Dr. Ruddy and Dr. Marik will act as lead investigators with Dr. Pierre Kory acting as contributing author. Patients interested in participating in the study should contact these clinics following their contact links listed in the following section below.